{"id":364722,"date":"2025-08-31T12:50:22","date_gmt":"2025-08-31T12:50:22","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-kymera-therapeutics\/"},"modified":"2025-08-31T12:50:22","modified_gmt":"2025-08-31T12:50:22","slug":"how-to-buy-kymera-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","title":{"rendered":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-364722","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - KYMR Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - KYMR Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Kymera Therapeutics (KYMR) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025 b\u00fcy\u00fcme kataliz\u00f6rlerini ve biyoteknoloji f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Kymera Therapeutics (KYMR) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025 b\u00fcy\u00fcme kataliz\u00f6rlerini ve biyoteknoloji f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131n\u0131 \u00f6\u011frenin."},"intro":"Bir sonraki biyoteknoloji devriminin bir par\u00e7as\u0131 olmak ister misiniz? Kymera Therapeutics (KYMR), hastal\u0131klar\u0131 tedavi etme \u015feklimizi d\u00f6n\u00fc\u015ft\u00fcrebilecek hedefe y\u00f6nelik protein y\u0131k\u0131m\u0131 teknolojisinde \u00f6nc\u00fcl\u00fck ediyor. Bu sadece ba\u015fka bir ila\u00e7 hissesi de\u011fil\u2014devasa b\u00fcy\u00fcme potansiyeline sahip ileri teknoloji bilime yat\u0131r\u0131m yapma \u015fans\u0131. KYMR'nin neden dikkatinizi hak etti\u011fini ve bu heyecan verici yolculu\u011fa nas\u0131l kat\u0131labilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Bir sonraki biyoteknoloji devriminin bir par\u00e7as\u0131 olmak ister misiniz? Kymera Therapeutics (KYMR), hastal\u0131klar\u0131 tedavi etme \u015feklimizi d\u00f6n\u00fc\u015ft\u00fcrebilecek hedefe y\u00f6nelik protein y\u0131k\u0131m\u0131 teknolojisinde \u00f6nc\u00fcl\u00fck ediyor. Bu sadece ba\u015fka bir ila\u00e7 hissesi de\u011fil\u2014devasa b\u00fcy\u00fcme potansiyeline sahip ileri teknoloji bilime yat\u0131r\u0131m yapma \u015fans\u0131. KYMR'nin neden dikkatinizi hak etti\u011fini ve bu heyecan verici yolculu\u011fa nas\u0131l kat\u0131labilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Kymera Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>31 A\u011fustos 2025 itibar\u0131yla Kymera Therapeutics (KYMR), NASDAQ'ta <strong>41,20 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik\u2014Kymera'n\u0131n 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131 tarih. Tarihsel olarak, bu raporlar biyoteknoloji sekt\u00f6r\u00fcnde fiyatlar\u0131 dramatik \u015fekilde hareket ettirir.<\/p> <h3><strong>Kazan\u00e7 Raporlar\u0131 KYMR Hissesini Nas\u0131l Hareket Ettirir<\/strong><\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>11 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>42,50 $<\/td><td>-%3,1 (tahminlerin alt\u0131nda)<\/td><\/tr> <tr><td>9 May\u0131s 2025<\/td><td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td><td>38,20 $<\/td><td>+%8,2 (pipeline ilerlemesi)<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>Y\u0131ll\u0131k Rapor<\/td><td>35,80 $<\/td><td>+%12,3 (ortakl\u0131k haberi)<\/td><\/tr> <tr><td>Kas 2024<\/td><td>Klinik G\u00fcncelleme<\/td><td>32,10 $<\/td><td>+%15,8 (pozitif veri)<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>29,50 $<\/td><td>-%6,2 (d\u00fczenleyici gecikme)<\/td><\/tr> <tr><td>May\u0131s 2024<\/td><td>FDA Atamas\u0131<\/td><td>26,80 $<\/td><td>+%45,6 (h\u0131zland\u0131r\u0131lm\u0131\u015f onay)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif klinik veriler ve d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131 genellikle %15-45 aras\u0131 y\u00fckseli\u015flere yol a\u00e7arken, kazan\u00e7 tahminlerinin tutmamas\u0131 ge\u00e7ici %3-6 d\u00fc\u015f\u00fc\u015flere neden olur ve genellikle pipeline haberleriyle h\u0131zla toparlan\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>Kymera hisseleri son alt\u0131 ayda <strong>%7,5 kazan\u00e7<\/strong> sa\u011flad\u0131, ancak yolculuk hi\u00e7 de sorunsuz olmad\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 35,80 $ (tatil sonras\u0131 konsolidasyon)<\/li> <li><strong>Mart 2025<\/strong>: 42,60 $ (Gilead ortakl\u0131k s\u00f6ylentileri)<\/li> <li><strong>Nisan 2025<\/strong>: 38,20 $ (kar realizasyonu d\u00f6nemi)<\/li> <li><strong>May\u0131s 2025<\/strong>: 41,30 $ (1. \u00e7eyrek kazan\u00e7 s\u00fcrprizi)<\/li> <li><strong>Haziran 2025<\/strong>: 47,80 $ (Gilead anla\u015fmas\u0131 onay\u0131 +750M $)<\/li> <li><strong>Temmuz 2025<\/strong>: 44,20 $ (piyasa volatilitesi)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 41,20 $ (2. \u00e7eyrek kazan\u00e7 tahminlerinin alt\u0131nda)<\/li> <\/ul> <p>Volatilitenin sebebi nedir? Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve ortakl\u0131k haberlerine ba\u011fl\u0131 olarak y\u00fckselir ve d\u00fc\u015fer. <strong>52 haftal\u0131k aral\u0131k 19,45 $ ile 53,27 $<\/strong> aras\u0131nda de\u011fi\u015ferek bu hissenin ne kadar patlay\u0131c\u0131 olabilece\u011fini g\u00f6steriyor (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/KYMR\/kymera-therapeutics\/stock-price-history\">MacroTrends<\/a>).<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 52-58 $ (3. ve 4. \u00e7eyrek kataliz\u00f6r etkisi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Projeksiyonu<\/strong>: 65-75 $ (klinik d\u00f6n\u00fcm noktalar\u0131n\u0131n ger\u00e7ekle\u015fmesi)<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 85-100 $ (ilk ticari lansmanlar)<\/li> <li><strong>2030 Vizyonu<\/strong>: 120-150 $ (piyasa liderli\u011fi konumu)<\/li> <\/ul> <p><strong>Karar<\/strong>: Bu, 5 y\u0131l i\u00e7inde 3-4 kat potansiyele sahip <strong>uzun vadeli bir bile\u015fik yat\u0131r\u0131m<\/strong>. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 30 Ekim kazan\u00e7lar\u0131n\u0131 yak\u0131ndan takip etmeli.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: KT-621 veya KT-579 programlar\u0131nda herhangi bir aksama hisseleri %30-50 d\u00fc\u015f\u00fcrebilir<\/li> <li><strong>D\u00fczenleyici engeller<\/strong>: FDA\/EMA de\u011fi\u015fiklikleri onaylar\u0131 geciktirebilir ve maliyetleri art\u0131rabilir<\/li> <li><strong>Nakit t\u00fcketimi<\/strong>: \u00c7eyreklik 78,4M $ AR-GE harcamas\u0131 devam eden finansman gerektirir (<a href=\"https:\/\/www.ainvest.com\/news\/kymera-therapeutics-q2-2025-earnings-test-resilience-tpd-space-2508\/\">AInvest<\/a>)<\/li> <li><strong>Rekabet<\/strong>: B\u00fcy\u00fck ila\u00e7 \u015firketlerinin TPD alan\u0131na girmesi marjlar\u0131 bask\u0131layabilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>750M $ Gilead anla\u015fmas\u0131<\/strong>: Kademeli teliflerle 85M $ \u00f6n \u00f6deme (<a href=\"https:\/\/www.gilead.com\/news\/news-details\/2025\/gilead-sciences-and-kymera-therapeutics-enter-into-exclusive-option-and-license-agreement-to-develop-novel-oral-molecular-glue-cdk2-degraders\">Gilead Sciences<\/a>)<\/li> <li><strong>FDA h\u0131zl\u0131 onay atamas\u0131<\/strong>: %45,58 hisse art\u0131\u015f\u0131 \u00f6nc\u00fcl\u00fc (<a href=\"https:\/\/www.timothysykes.com\/news\/kymera-therapeutics-inc-kymr-news-2025_06_02\/\">Timothy Sykes<\/a>)<\/li> <li><strong>1 milyar $ nakit rezervi<\/strong>: 2028'e kadar finansman sa\u011fland\u0131<\/li> <li><strong>20 analist \"Al\" notu<\/strong>: Oybirli\u011fiyle profesyonel g\u00fcven<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-5'ini y\u00fcksek riskli biyoteknolojiye ay\u0131r\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Haftal\u0131k 100-200 $ al\u0131m yaparak zamanlama hatalar\u0131ndan ka\u00e7\u0131n\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 40 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015flerde al\u0131m, 50 $ \u00fczerindeki y\u00fckseli\u015flerde kar al\u0131m\u0131 yap\u0131n<\/li> <li><strong>\u00c7e\u015fitlendirin<\/strong>: Dengeli olarak stabil temett\u00fc hisseleriyle destekleyin<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"KYMR ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici at\u0131l\u0131mlar ve ara s\u0131ra laboratuvar patlamalar\u0131. G\u00fcvenlik g\u00f6zl\u00fc\u011f\u00fcn\u00fcz\u00fc takmay\u0131 unutmay\u0131n!\"<\/li> <\/ol> <h2>\u2705 Kymera Therapeutics (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir i\u015flem platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve d\u00fc\u015f\u00fck \u00fccretler sa\u011flayan<\/td><\/tr> <tr><td>2<\/td><td>Hesap a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc i\u00e7in 500-1000 $ ile ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"KYMR\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131n\u0131 kontrol edin (%1'in alt\u0131nda ideal)<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Giri\u015f fiyat\u0131n\u0131n %15-20 alt\u0131nda stop-loss belirleyin<\/td><\/tr> <tr><td>7<\/td><td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td><td>KYMR hen\u00fcz temett\u00fc \u00f6demiyor\u2014b\u00fcy\u00fcmeye odaklan\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Haber ak\u0131\u015f\u0131n\u0131 takip edin<\/td><td>Biyoteknoloji haber uyar\u0131lar\u0131na abone olun<\/td><\/tr> <tr><td>9<\/td><td>\u00c7eyreklik de\u011ferlendirme yap\u0131n<\/td><td>Her kazan\u00e7 raporundan sonra yeniden de\u011ferlendirin<\/td><\/tr> <tr><td>10<\/td><td>Vergi etkilerini g\u00f6z \u00f6n\u00fcnde bulundurun<\/td><td>Daha iyi sermaye kazanc\u0131 i\u00e7in 1 y\u0131ldan fazla tutun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> \u2014 Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>1 dakikal\u0131k do\u011frulama<\/strong> \u2014 Tek belge KYC ile an\u0131nda i\u015flem yap\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 Kripto, e-c\u00fczdanlar, banka transferleri mevcut<\/li> <li><strong>Par\u00e7al\u0131 hisse al\u0131m\u0131<\/strong> \u2014 KYMR gibi pahal\u0131 hisselerin k\u0131smi paylar\u0131n\u0131 al\u0131n<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Kymera: Protein Y\u0131k\u0131m\u0131 \u00d6nc\u00fcs\u00fc<\/h2> <p>Kymera Therapeutics sadece ba\u015fka bir biyoteknoloji \u015firketi de\u011fil\u2014hedefe y\u00f6nelik protein y\u0131k\u0131m\u0131 devrimini liderlik ediyor. \u015eirketin teknolojisi, hastal\u0131\u011fa neden olan proteinleri sadece engellemek yerine \"molek\u00fcler yap\u0131\u015ft\u0131r\u0131c\u0131lar\" kullanarak ortadan kald\u0131r\u0131yor ve daha \u00f6nce ila\u00e7la tedavi edilemeyen durumlar\u0131 potansiyel olarak tedavi ediyor.<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: Kymera'n\u0131n bilim insanlar\u0131, protein y\u0131k\u0131c\u0131lar\u0131n\u0131n o kadar spesifik \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 ke\u015ffettiler ki, sa\u011fl\u0131kl\u0131 proteinlere zarar vermeden sadece hastal\u0131k proteinlerini hedefleyebiliyorlar\u2014normal dokuyu etkilemeden sadece kanser h\u00fccrelerini yok eden ak\u0131ll\u0131 bir f\u00fcze gibi!<\/p> <p>Daha fazla e\u011fitim i\u00e7eri\u011fi ve piyasa analizleri i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> sayfam\u0131z\u0131 ziyaret edin; karma\u015f\u0131k yat\u0131r\u0131m kavramlar\u0131n\u0131 basit, uygulanabilir stratejilere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyoruz.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Kymera Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>31 A\u011fustos 2025 itibar\u0131yla Kymera Therapeutics (KYMR), NASDAQ&#8217;ta <strong>41,20 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik\u2014Kymera&#8217;n\u0131n 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131 tarih. Tarihsel olarak, bu raporlar biyoteknoloji sekt\u00f6r\u00fcnde fiyatlar\u0131 dramatik \u015fekilde hareket ettirir.<\/p>\n<h3><strong>Kazan\u00e7 Raporlar\u0131 KYMR Hissesini Nas\u0131l Hareket Ettirir<\/strong><\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>11 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>42,50 $<\/td>\n<td>-%3,1 (tahminlerin alt\u0131nda)<\/td>\n<\/tr>\n<tr>\n<td>9 May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>38,20 $<\/td>\n<td>+%8,2 (pipeline ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Rapor<\/td>\n<td>35,80 $<\/td>\n<td>+%12,3 (ortakl\u0131k haberi)<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>Klinik G\u00fcncelleme<\/td>\n<td>32,10 $<\/td>\n<td>+%15,8 (pozitif veri)<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>29,50 $<\/td>\n<td>-%6,2 (d\u00fczenleyici gecikme)<\/td>\n<\/tr>\n<tr>\n<td>May\u0131s 2024<\/td>\n<td>FDA Atamas\u0131<\/td>\n<td>26,80 $<\/td>\n<td>+%45,6 (h\u0131zland\u0131r\u0131lm\u0131\u015f onay)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif klinik veriler ve d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131 genellikle %15-45 aras\u0131 y\u00fckseli\u015flere yol a\u00e7arken, kazan\u00e7 tahminlerinin tutmamas\u0131 ge\u00e7ici %3-6 d\u00fc\u015f\u00fc\u015flere neden olur ve genellikle pipeline haberleriyle h\u0131zla toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>Kymera hisseleri son alt\u0131 ayda <strong>%7,5 kazan\u00e7<\/strong> sa\u011flad\u0131, ancak yolculuk hi\u00e7 de sorunsuz olmad\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 35,80 $ (tatil sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Mart 2025<\/strong>: 42,60 $ (Gilead ortakl\u0131k s\u00f6ylentileri)<\/li>\n<li><strong>Nisan 2025<\/strong>: 38,20 $ (kar realizasyonu d\u00f6nemi)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 41,30 $ (1. \u00e7eyrek kazan\u00e7 s\u00fcrprizi)<\/li>\n<li><strong>Haziran 2025<\/strong>: 47,80 $ (Gilead anla\u015fmas\u0131 onay\u0131 +750M $)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 44,20 $ (piyasa volatilitesi)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 41,20 $ (2. \u00e7eyrek kazan\u00e7 tahminlerinin alt\u0131nda)<\/li>\n<\/ul>\n<p>Volatilitenin sebebi nedir? Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131 ve ortakl\u0131k haberlerine ba\u011fl\u0131 olarak y\u00fckselir ve d\u00fc\u015fer. <strong>52 haftal\u0131k aral\u0131k 19,45 $ ile 53,27 $<\/strong> aras\u0131nda de\u011fi\u015ferek bu hissenin ne kadar patlay\u0131c\u0131 olabilece\u011fini g\u00f6steriyor (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/KYMR\/kymera-therapeutics\/stock-price-history\">MacroTrends<\/a>).<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 52-58 $ (3. ve 4. \u00e7eyrek kataliz\u00f6r etkisi) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 65-75 $ (klinik d\u00f6n\u00fcm noktalar\u0131n\u0131n ger\u00e7ekle\u015fmesi)<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 85-100 $ (ilk ticari lansmanlar)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 120-150 $ (piyasa liderli\u011fi konumu)<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: Bu, 5 y\u0131l i\u00e7inde 3-4 kat potansiyele sahip <strong>uzun vadeli bir bile\u015fik yat\u0131r\u0131m<\/strong>. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 30 Ekim kazan\u00e7lar\u0131n\u0131 yak\u0131ndan takip etmeli.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: KT-621 veya KT-579 programlar\u0131nda herhangi bir aksama hisseleri %30-50 d\u00fc\u015f\u00fcrebilir<\/li>\n<li><strong>D\u00fczenleyici engeller<\/strong>: FDA\/EMA de\u011fi\u015fiklikleri onaylar\u0131 geciktirebilir ve maliyetleri art\u0131rabilir<\/li>\n<li><strong>Nakit t\u00fcketimi<\/strong>: \u00c7eyreklik 78,4M $ AR-GE harcamas\u0131 devam eden finansman gerektirir (<a href=\"https:\/\/www.ainvest.com\/news\/kymera-therapeutics-q2-2025-earnings-test-resilience-tpd-space-2508\/\">AInvest<\/a>)<\/li>\n<li><strong>Rekabet<\/strong>: B\u00fcy\u00fck ila\u00e7 \u015firketlerinin TPD alan\u0131na girmesi marjlar\u0131 bask\u0131layabilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>750M $ Gilead anla\u015fmas\u0131<\/strong>: Kademeli teliflerle 85M $ \u00f6n \u00f6deme (<a href=\"https:\/\/www.gilead.com\/news\/news-details\/2025\/gilead-sciences-and-kymera-therapeutics-enter-into-exclusive-option-and-license-agreement-to-develop-novel-oral-molecular-glue-cdk2-degraders\">Gilead Sciences<\/a>)<\/li>\n<li><strong>FDA h\u0131zl\u0131 onay atamas\u0131<\/strong>: %45,58 hisse art\u0131\u015f\u0131 \u00f6nc\u00fcl\u00fc (<a href=\"https:\/\/www.timothysykes.com\/news\/kymera-therapeutics-inc-kymr-news-2025_06_02\/\">Timothy Sykes<\/a>)<\/li>\n<li><strong>1 milyar $ nakit rezervi<\/strong>: 2028&#8217;e kadar finansman sa\u011fland\u0131<\/li>\n<li><strong>20 analist &#8220;Al&#8221; notu<\/strong>: Oybirli\u011fiyle profesyonel g\u00fcven<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn sadece %2-5&#8217;ini y\u00fcksek riskli biyoteknolojiye ay\u0131r\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Haftal\u0131k 100-200 $ al\u0131m yaparak zamanlama hatalar\u0131ndan ka\u00e7\u0131n\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: 40 $ alt\u0131ndaki d\u00fc\u015f\u00fc\u015flerde al\u0131m, 50 $ \u00fczerindeki y\u00fckseli\u015flerde kar al\u0131m\u0131 yap\u0131n<\/li>\n<li><strong>\u00c7e\u015fitlendirin<\/strong>: Dengeli olarak stabil temett\u00fc hisseleriyle destekleyin<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;KYMR ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici at\u0131l\u0131mlar ve ara s\u0131ra laboratuvar patlamalar\u0131. G\u00fcvenlik g\u00f6zl\u00fc\u011f\u00fcn\u00fcz\u00fc takmay\u0131 unutmay\u0131n!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Kymera Therapeutics (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir i\u015flem platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve d\u00fc\u015f\u00fck \u00fccretler sa\u011flayan<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc i\u00e7in 500-1000 $ ile ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;KYMR&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131n\u0131 kontrol edin (%1&#8217;in alt\u0131nda ideal)<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131n %15-20 alt\u0131nda stop-loss belirleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td>\n<td>KYMR hen\u00fcz temett\u00fc \u00f6demiyor\u2014b\u00fcy\u00fcmeye odaklan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Haber ak\u0131\u015f\u0131n\u0131 takip edin<\/td>\n<td>Biyoteknoloji haber uyar\u0131lar\u0131na abone olun<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u00c7eyreklik de\u011ferlendirme yap\u0131n<\/td>\n<td>Her kazan\u00e7 raporundan sonra yeniden de\u011ferlendirin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Vergi etkilerini g\u00f6z \u00f6n\u00fcnde bulundurun<\/td>\n<td>Daha iyi sermaye kazanc\u0131 i\u00e7in 1 y\u0131ldan fazla tutun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option, biyoteknoloji yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> \u2014 Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>1 dakikal\u0131k do\u011frulama<\/strong> \u2014 Tek belge KYC ile an\u0131nda i\u015flem yap\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> \u2014 Kripto, e-c\u00fczdanlar, banka transferleri mevcut<\/li>\n<li><strong>Par\u00e7al\u0131 hisse al\u0131m\u0131<\/strong> \u2014 KYMR gibi pahal\u0131 hisselerin k\u0131smi paylar\u0131n\u0131 al\u0131n<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Kymera: Protein Y\u0131k\u0131m\u0131 \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Kymera Therapeutics sadece ba\u015fka bir biyoteknoloji \u015firketi de\u011fil\u2014hedefe y\u00f6nelik protein y\u0131k\u0131m\u0131 devrimini liderlik ediyor. \u015eirketin teknolojisi, hastal\u0131\u011fa neden olan proteinleri sadece engellemek yerine &#8220;molek\u00fcler yap\u0131\u015ft\u0131r\u0131c\u0131lar&#8221; kullanarak ortadan kald\u0131r\u0131yor ve daha \u00f6nce ila\u00e7la tedavi edilemeyen durumlar\u0131 potansiyel olarak tedavi ediyor.<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: Kymera&#8217;n\u0131n bilim insanlar\u0131, protein y\u0131k\u0131c\u0131lar\u0131n\u0131n o kadar spesifik \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 ke\u015ffettiler ki, sa\u011fl\u0131kl\u0131 proteinlere zarar vermeden sadece hastal\u0131k proteinlerini hedefleyebiliyorlar\u2014normal dokuyu etkilemeden sadece kanser h\u00fccrelerini yok eden ak\u0131ll\u0131 bir f\u00fcze gibi!<\/p>\n<p>Daha fazla e\u011fitim i\u00e7eri\u011fi ve piyasa analizleri i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> sayfam\u0131z\u0131 ziyaret edin; karma\u015f\u0131k yat\u0131r\u0131m kavramlar\u0131n\u0131 basit, uygulanabilir stratejilere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyoruz.<\/p>\n"},"faq":[{"question":"Kymera Therapeutics hisseleri nereden al\u0131n\u0131r?","answer":"Kymera Therapeutics hisseleri NASDAQ borsas\u0131nda KYMR sembol\u00fc ile i\u015flem g\u00f6r\u00fcr. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"KYMR hissesinin 2025 sonu fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in KYMR hissesinin fiyat\u0131n\u0131n 52-58 $ aral\u0131\u011f\u0131nda olmas\u0131 beklenmektedir ve bu d\u00f6nemde g\u00fc\u00e7l\u00fc al\u0131m sinyalleri vard\u0131r."},{"question":"Kymera Therapeutics'in ana riskleri nelerdir?","answer":"Ana riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici engeller, y\u00fcksek nakit t\u00fcketimi ve artan rekabet yer almaktad\u0131r."},{"question":"KYMR hissesi i\u00e7in yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131rmak, dolar maliyeti ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak ve haberleri yak\u0131ndan takip etmek \u00f6nemlidir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve par\u00e7al\u0131 hisse al\u0131m\u0131 gibi avantajlar sunarak biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 eri\u015filebilir k\u0131lar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Kymera Therapeutics hisseleri nereden al\u0131n\u0131r?","answer":"Kymera Therapeutics hisseleri NASDAQ borsas\u0131nda KYMR sembol\u00fc ile i\u015flem g\u00f6r\u00fcr. G\u00fcvenilir bir arac\u0131 kurum veya online i\u015flem platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"KYMR hissesinin 2025 sonu fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in KYMR hissesinin fiyat\u0131n\u0131n 52-58 $ aral\u0131\u011f\u0131nda olmas\u0131 beklenmektedir ve bu d\u00f6nemde g\u00fc\u00e7l\u00fc al\u0131m sinyalleri vard\u0131r."},{"question":"Kymera Therapeutics'in ana riskleri nelerdir?","answer":"Ana riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici engeller, y\u00fcksek nakit t\u00fcketimi ve artan rekabet yer almaktad\u0131r."},{"question":"KYMR hissesi i\u00e7in yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131rmak, dolar maliyeti ortalamas\u0131 yapmak, fiyat uyar\u0131lar\u0131 kurmak ve haberleri yak\u0131ndan takip etmek \u00f6nemlidir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ve par\u00e7al\u0131 hisse al\u0131m\u0131 gibi avantajlar sunarak biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 eri\u015filebilir k\u0131lar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-31T12:50:22+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-31T12:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\",\"name\":\"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-31T12:50:22+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-31T12:50:22+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-31T12:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/","name":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-31T12:50:22+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kymera-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Kymera Therapeutics, Inc. (KYMR) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Kymera Therapeutics, Inc. (KYMR) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":364717,"slug":"how-to-buy-kymera-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kymera Therapeutics, Inc. (KYMR)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":364721,"slug":"how-to-buy-kymera-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Kymera Therapeutics, Inc. (KYMR) - Investimento em a\u00e7\u00f5es da Kymera Therapeutics, Inc. (KYMR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-kymera-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/364722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=364722"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/364722\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=364722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=364722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=364722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}